| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 18.762 | 18.281 | 30.541 | 40.114 |
| Total Income - EUR | - | - | - | - | - | - | 24.754 | 38.537 | 40.158 | 48.525 |
| Total Expenses - EUR | - | - | - | - | - | - | 18.791 | 36.530 | 42.560 | 46.065 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 5.963 | 2.006 | -2.402 | 2.459 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 5.957 | 1.824 | -2.707 | 1.256 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Cmi Dr. Igna Silvia S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 17.237 | 52.103 | 50.003 | 40.551 |
| Current Assets | - | - | - | - | - | - | 66.608 | 22.378 | 4.201 | 7.014 |
| Inventories | - | - | - | - | - | - | 17.629 | 18 | 167 | 249 |
| Receivables | - | - | - | - | - | - | 39.784 | 20.440 | 1.767 | 2.805 |
| Cash | - | - | - | - | - | - | 9.195 | 1.921 | 2.267 | 3.960 |
| Shareholders Funds | - | - | - | - | - | - | 5.997 | 7.839 | 5.108 | 6.336 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 4.416 | 13.242 | 8.213 | 8.972 |
| Income in Advance | - | - | - | - | - | - | 73.458 | 53.430 | 40.960 | 32.323 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Cmi Dr. Igna Silvia S.r.l.